Results 131 to 140 of about 101,340 (329)
Safety and Effect of 12‐Month Ecopipam Treatment in Pediatric Patients with Tourette Syndrome
Movement Disorders Clinical Practice, EarlyView.Abstract Background Tourette syndrome (TS) is a chronic neurodevelopmental tic disorder with a considerable quality of life (QOL) burden. Objectives The goal was to determine the long‐term safety, tolerability, and clinical effects of ecopipam, a first‐in‐class dopamine D1 receptor antagonist, for TS.
Donald L. Gilbert +7 more
wiley +1 more source
Differential effects of dopamine agonists upon stimulated limbic and striatal dopamine release: in vivo voltammetric data [PDF]
, 1991 Jonathan A. Stamford +2 more
openalex +1 more source
Speech Differences between Multiple System Atrophy and Parkinson's Disease
Movement Disorders Clinical Practice, EarlyView.Abstract Background Delineation of Parkinson's disease (PD) from multiple system atrophy (MSA) can be challenging in early disease stages. Speech characteristics have been studied as digital biomarkers in PD and ataxias. Currently, data on speech in MSA is limited.
Tom Hähnel +9 more
wiley +1 more source
Movement Disorders Clinical Practice, EarlyView.Abstract Background Non‐motor fluctuations, characterized by variability in mood and cognition, are prevalent in advanced Parkinson's disease (PD), but less is known about these fluctuations in early PD. Objective The objective was to characterize fluctuations in cognition and mood in early PD without cognitive impairment.
Abhimanyu Mahajan +4 more
wiley +1 more source
Movement Disorders Clinical Practice, EarlyView.ABSTRACT Background DaxibotulinumtoxinA (DAXI), a novel botulinum neurotoxin (BoNT) formulation, was shown to be safe, effective, and long‐lasting in the treatment of cervical dystonia (CD) over one treatment cycle in the phase 3, randomized, placebo‐controlled ASPEN‐1 trial.
Peter McAllister +11 more
wiley +1 more source
Dopamine agonists and risk of lung cancer in patients with restless legs syndrome. [PDF]
Pharmacoepidemiol Drug Saf, 2023 Hernandez-Con P +3 more
europepmc +1 more source
Dopamine D-3 receptors regulate GABA(A) receptor function through a phospho-dependent endocytosis mechanism in nucleus accumbens [PDF]
, 2006 The dopamine D-3 receptor, which is highly enriched in nucleus accumbens (NAc), has been suggested to play an important role in reinforcement and reward.
Chen, GJ, Kittler, JT, Moss, SJ, Yan, Z
core
Movement Disorders Clinical Practice, EarlyView.Abstract Background The coexistence of tics with Parkinson's disease (PD) is rare, as they often emerge at different ages, follow different trajectories and involve contrasting pathophysiological mechanisms related to dopamine availability and function in the brain. Cases We present 10 individuals with primary tic disorders who later developed PD.
Tarig Abkur +11 more
wiley +1 more source
Erratum to Current status of dopamine agonists in Parkinson’s disease [PDF]
, 1996 J L Montastruc +2 more
openalex +1 more source
Effects of dance therapy on balance, gait and neuro-psychological performances in patients with Parkinson's disease and postural instability [PDF]
, 2012 Postural Instability (PI) is a core feature of Parkinson’s Disease (PD) and a major cause of falls and disabilities. Impairment of executive functions has been called as an aggravating factor on motor performances. Dance therapy has been shown effective
Agnetti, Virgilio +6 more
core